FeesSafety
Pluang+

Moleculin secures Korean patent for Annamycin reconstitution, boosting global IP amid Phase 3 trial progress

Company Fundamentals
18 Nov 2026, 15:35 WIB
GlobeNewsWire
View Source
Bullish
Moleculin secures Korean patent for Annamycin reconstitution, boosting global IP amid Phase 3 trial progress

Moleculin Biotech has been granted a patent in South Korea for its method of reconstituting liposomal Annamycin, expanding its intellectual property protection across more than 20 jurisdictions worldwide. This patent strengthens Moleculin's multi-layered IP portfolio, which covers formulation, reconstitution, and lung-targeted therapies, supporting its ongoing Phase 3 MIRACLE trial for relapsed or refractory acute myeloid leukemia (AML). The expanded global patent coverage enhances the company's strategic position for future commercialization and partnerships as Annamycin advances toward potential regulatory approval.

Moleculin's patent expansion in South Korea provides context for readers interested in biotech innovations. For readers following the health sector, here is Pluang's market snapshot as of Nov 18, 2026 20:32 WIB: out of 150 priced US health stocks, 46 rose and 96 fell. Notable movers include MDLN at USD 36.12 (-4.13%), SMMT at USD 10.33 (-3.19%) with 70% sell order activity, and ABEO at USD 2.68 (+3.08%) with 97% sell order activity.

More News

Dividend 15 Split Corp. declares monthly dividends for Class A and Preferred shares payable December 10, 2026.

Dividend 15 Split Corp. declares monthly dividends for Class A and Preferred shares payable December 10, 2026.

Dividend 15 Split Corp. announced monthly dividend payments of $0.10 per Class A share and $0.05833 per Preferred share, payable on December 10, 2026, to shareholders recorded by November 30, 2026. Since inception, Class A shares have distributed $29...

Company Fundamentals
Neutral
52 minutes ago
Stewards launches SBC Express, offering up to $10,000 to small businesses within two hours using AI underwriting.

Stewards launches SBC Express, offering up to $10,000 to small businesses within two hours using AI underwriting.

Stewards Inc. has launched SBC Express, a new AI-enabled digital financing product that allows qualified small businesses to apply for and receive up to $10,000 in revenue-based financing in as little as two hours. The platform integrates application...

Market News
Bullish
52 minutes ago
VolitionRx downgraded to Hold despite progress in cancer and sepsis diagnostics.

VolitionRx downgraded to Hold despite progress in cancer and sepsis diagnostics.

Freedom Broker downgraded VolitionRx to Hold while the company reported significant advancements in its Nu.Q diagnostic platform, including over 95% accuracy in early-stage cancer detection and peer-reviewed validation in sepsis. VolitionRx expanded ...

Analyst Insights
Neutral
1 hour ago
Lowe's beats Q3 earnings estimates and raises full-year sales outlook.

Lowe's beats Q3 earnings estimates and raises full-year sales outlook.

Lowe's reported adjusted earnings per share of $3.10, surpassing estimates of $2.88, and revenue of $22.80 billion, beating the $22.40 billion forecast. Comparable sales rose 1.8%, driven by strong online and professional services sales. The company ...

Company Fundamentals
Bullish
1 hour ago
Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Daxor Corporation announced that a major Memphis health system has expanded its Blood Volume Analysis (BVA) program to an additional hospital outpatient site using Daxor’s ezBVA Lab service. This expansion allows the outpatient clinic to receive bloo...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App